Total Payments
$8,209
2024 Payments
$86.87
Companies
25
Transactions
193
Medicare Patients
769
Medicare Billing
$47,529
Payment Breakdown by Category
Food & Beverage$5,871 (71.5%)
Consulting$1,860 (22.7%)
Education$437.68 (5.3%)
Other$40.29 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,871 | 183 | 71.5% |
| Consulting Fee | $1,860 | 1 | 22.7% |
| Education | $437.68 | 7 | 5.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40.29 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $1,959 | 3 | $0 (2024) |
| ABBVIE INC. | $1,640 | 37 | $0 (2023) |
| Janssen Biotech, Inc. | $554.43 | 14 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $544.90 | 19 | $0 (2023) |
| Almirall LLC | $444.04 | 21 | $0 (2023) |
| GENZYME CORPORATION | $415.92 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $381.30 | 16 | $0 (2022) |
| PFIZER INC. | $338.06 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $283.50 | 6 | $0 (2023) |
| VYNE Pharmaceuticals Inc. | $273.66 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.87 | 2 | PFIZER INC. ($60.89) |
| 2023 | $946.42 | 13 | Sun Pharmaceutical Industries Inc. ($285.65) |
| 2022 | $1,870 | 36 | ABBVIE INC. ($407.50) |
| 2021 | $5,306 | 142 | Incyte Corporation ($1,860) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/07/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $60.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.98 | General |
| Category: Dermatology | ||||||
| 09/06/2023 | Sun Pharmaceutical Industries Inc. | — | Food and Beverage | In-kind items and services | $21.32 | General |
| 09/05/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $133.62 | General |
| Category: Dermatology | ||||||
| 09/05/2023 | Sun Pharmaceutical Industries Inc. | — | Food and Beverage | In-kind items and services | $28.51 | General |
| 08/01/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $76.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/27/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $102.20 | General |
| Category: Dermatology | ||||||
| 04/12/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $70.42 | General |
| Category: Immunology | ||||||
| 03/28/2023 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Dermatology | ||||||
| 03/15/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $113.88 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 02/22/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $72.68 | General |
| Category: DERMATOLOGY | ||||||
| 02/22/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $66.03 | General |
| Category: DERMATOLOGY | ||||||
| 01/04/2023 | ABBVIE INC. | RINVOQ (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $90.22 | General |
| Category: Inflammation & Immunology | ||||||
| 12/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/03/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $73.25 | General |
| Category: Dermatology | ||||||
| 09/28/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: DERMATOLOGY | ||||||
| 09/28/2022 | Almirall LLC | Klisyri (Drug) | Food and Beverage | Cash or cash equivalent | $5.16 | General |
| Category: Dermatology | ||||||
| 09/07/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Immunology | ||||||
| 09/06/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Education | In-kind items and services | $91.99 | General |
| Category: Immunology | ||||||
| 08/31/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $85.48 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 222 | 276 | $56,974 | $9,557 |
| 2022 | 8 | 299 | 424 | $84,137 | $19,145 |
| 2021 | 8 | 228 | 408 | $44,858 | $17,434 |
| 2020 | 1 | 20 | 26 | $3,184 | $1,393 |
Total Patients
769
Total Services
1,134
Medicare Billing
$47,529
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 65 | $11,180 | $2,499 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $9,180 | $1,765 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 25 | $6,375 | $1,356 | 21.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 24 | 25 | $6,525 | $1,222 | 18.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 23 | 25 | $9,500 | $1,092 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,460 | $781.31 | 14.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 29 | 30 | $5,730 | $645.65 | 11.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 15 | 56 | $3,024 | $196.44 | 6.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 74 | $12,661 | $3,910 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $13,120 | $3,264 | 24.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 50 | 51 | $18,100 | $2,761 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $10,807 | $2,732 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 33 | $8,329 | $2,506 | 30.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 30 | 35 | $8,821 | $2,384 | 27.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 32 | 35 | $6,517 | $1,077 | 16.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 19 | 116 | $5,781 | $512.42 | 8.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 94 | $13,928 | $5,693 | 40.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 36 | 47 | $8,578 | $3,542 | 41.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 34 | 34 | $6,267 | $2,434 | 38.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 30 | 36 | $5,994 | $2,076 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 15 | $3,162 | $1,233 | 39.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 25 | 37 | $3,948 | $1,148 | 29.1% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 14 | 20 | $1,717 | $743.86 | 43.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 13 | 125 | $1,264 | $563.99 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 26 | $3,184 | $1,393 | 43.7% |
About Yasmin Mathlin
Yasmin Mathlin is a Nurse Practitioner healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1902385784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yasmin Mathlin has received a total of $8,209 in payments from pharmaceutical and medical device companies, with $86.87 received in 2024. These payments were reported across 193 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,871).
As a Medicare-enrolled provider, Mathlin has provided services to 769 Medicare beneficiaries, totaling 1,134 services with total Medicare billing of $47,529. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Primary Care, Adult Health
- Location Durham, NC
- Active Since 08/12/2018
- Last Updated 03/14/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902385784
Products in Payments
- DUPIXENT (Biological) $759.44
- RINVOQ (Biological) $622.31
- TREMFYA (Drug) $596.51
- SKYRIZI (Biological) $463.05
- HUMIRA (Biological) $438.20
- COSENTYX (Biological) $381.30
- ZILXI (Drug) $251.27
- Seysara (Drug) $234.04
- Klisyri (Drug) $199.00
- EUCRISA (Drug) $186.95
- Winlevi (Drug) $168.23
- ILUMYA (Biological) $155.90
- Cimzia (Drug) $153.13
- DUOBRII (Drug) $132.12
- ARAZLO (Drug) $125.88
- Ilumya (Biological) $124.06
- AKLIEF (Drug) $109.51
- ADBRY (Biological) $104.20
- OPZELURA (Drug) $99.23
- CIBINQO (Drug) $90.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Durham
Cynthia Simonson, Np, NP
Nurse Practitioner — Payments: $39,044
Nurse Practitioner $39,044
Jennifer Tenhover, Np, NP
Nurse Practitioner — Payments: $22,357
Nurse Practitioner $22,357
Kristi Wiggins, Msn, Anp, Aprn-Bc, MSN, ANP, APRN-BC
Nurse Practitioner — Payments: $17,638
Nurse Practitioner $17,638
Christine Anderson, Np-C, NP-C
Nurse Practitioner — Payments: $16,449
Nurse Practitioner $16,449
Mrs. Anderson Garrett, Agpcnp-Bc, AGPCNP-BC
Nurse Practitioner — Payments: $14,836
Nurse Practitioner $14,836
Kathryn Kreider, Np, NP
Nurse Practitioner — Payments: $11,654
Nurse Practitioner $11,654